EP Patent

EP3088418A1 — Pharmaceutical compound

Assigned to Vallaurix Pte Ltd · Expires 2016-11-02 · 10y expired

What this patent protects

The present invention relates to an alpha-MSH analogue compound, the use in skin diseases, and the preparation.

USPTO Abstract

The present invention relates to an alpha-MSH analogue compound, the use in skin diseases, and the preparation.

Drugs covered by this patent

Scenesse (AFAMELANOTIDE) · Clivunel Inc

Patent Metadata

Patent number: EP3088418A1
Jurisdiction: EP
Classification: —
Expires: 2016-11-02
Drug substance claim: No
Drug product claim: No
Assignee: Vallaurix Pte Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.